Merck to seek approval for two cardiovascular drugs in '13

(Reuters) - Merck & Co said on Sunday it plans to file regulatory applications for a new type of blood clot preventer next year, and will also file with regulators for approval of another cardiovascular drug in 2013. The pharmaceutical company said in a statement that it is in discussions with regulatory agencies over vorapaxar, a drug that has been dogged by bleeding concerns since January 2011, when a safety committee overseeing a large study said the new type of anti-platelet drug was not appropriate for patients who had suffered a stroke. ... Original Source